Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.
about
Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finInduction of senescence-like phenotypes by forced expression of hic-5, which encodes a novel LIM motif protein, in immortalized human fibroblastsHuman monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitorDistal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteasesThe anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesiclesAccessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitorStructural basis of substrate specificity in the serine proteasesPlasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbitsPlasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosisSecretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expressionPost-transcriptional regulation of gene expression in the plasminogen activation system.A serpin shapes the extracellular environment to prevent influenza A virus maturationMolecular cloning of a serine proteinase inhibitor from Brugia malayiExpression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion.Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms.Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.Impact of the -675 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene on childhood IgA nephropathy.Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes.Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils.PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis.cDNA cloning and expression in E. coli of a plasminogen activator inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cell.The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells.Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteriesThe fibrinolytic system of the vessel wall and its role in the control of thrombosis.Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular DiseaseStructural comparisons of the native and reactive-centre-cleaved forms of alpha 1-antitrypsin by neutron- and X-ray-scattering in solution.mRNA expression of urokinase and plasminogen activator inhibitor-1 in human crescentic glomerulonephritis.Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: The roles of PAI-1 and obesity on stroke.Plasminogen activation: biochemistry, physiology, and therapeutics.Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.Tryptophan properties in fluorescence and functional stability of plasminogen activator inhibitor 1.Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 hnRNA.Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications.Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor.cDNA for bovine type 1 plasminogen activator inhibitor (PAI-1)The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene.
P2860
Q24300911-96C51975-3DA5-451E-B733-D1D666FA4E72Q24647178-87AC48F6-BAF8-4244-BAC9-D7FCAD8B8A3EQ24682654-C796960D-C0C5-43D7-BB1D-E77E432C29DBQ24793473-A36F98F7-FE3B-4DB9-98F8-7A980A472103Q28579043-07E53A6B-0B54-4B39-B6DE-EF5C67FF5FCAQ28647054-22A21BAD-2901-4581-9ED7-05FBABBA81D3Q29619675-208FFC98-30AF-47A1-9551-8E3C14549872Q33781945-272C7B76-9313-464A-B496-052CC13AF02BQ33848439-6FC015B3-EC36-4660-B4F8-5B551E2BE962Q34372572-16DD5CC6-0F74-490F-A95D-9FAC3A13B67AQ34379086-04291597-83D0-4EDA-97F6-57BA153660A1Q34559926-5007FAE5-2A3E-4009-BFBE-D07739CE0494Q34584801-D1002E0B-DA83-43DC-83B8-E0622A92E129Q35083702-AAF63F20-BC8E-4BA3-9FFC-C467E92F5BC7Q35408717-3675D4A1-E381-46D5-8400-746782BBDBF0Q35751580-7DB1D41A-72D2-440F-BB3C-F244F3BFC51DQ35765078-88B557F7-B28B-4202-96FA-2DD56DE7C981Q36218668-208EEC53-8CD0-46F2-94C8-DA107795DE67Q36222413-B5B82DAD-5BE5-4EE3-B39F-59970C9661B9Q36224280-2F079260-75E7-4875-9D21-D46F7DC2B622Q36355159-8BB89E28-0333-406C-A804-D0477DCCA75DQ36356179-1860D748-14EE-44A9-843E-C59F35A8891DQ36386574-0FF2C716-2CF4-4A30-9CBB-8E04F5225EC8Q36426170-B63F6DB8-10EE-4375-823F-7CE1E15D3D68Q36722539-270FA39F-973A-4029-A426-F293823AD963Q36920255-4764E5B7-5FE9-410A-B354-BC1D5120102AQ37131350-AC0540B2-4C7F-40B9-A7D7-6EBEFE568E78Q38000918-53165F4D-C647-4653-BB30-BA3E2213E820Q38128321-075AE3FA-85EF-4BD3-9694-C1591C5EF90BQ38341345-C1497942-ED5B-4A31-97E1-96710200DD49Q38524501-0307BFF2-D591-4541-A069-F7577B6371AEQ39220804-E5A4633D-51A4-4714-8C1C-ABE8ECDDF08AQ39489577-1C522441-BA20-4BDA-90D8-D67212E9468FQ39508019-819EFF57-E117-4EDE-9747-A928254BC383Q40243697-88F94680-2424-4A9D-B1BF-EDFE367A983FQ40406056-F8CDCE7B-0429-4538-8F95-C5C7DA57CA2CQ40475372-0458AFE8-1664-4C4B-8659-AA3273F6E384Q40530719-B68859D3-A8A2-43A4-8C8B-3940E6F1349FQ40538806-F06F3D3B-930D-4011-9283-F4E355843F1EQ40545045-C16CBCAB-7448-4A21-97D0-94728095D4F1
P2860
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Cloning and sequence of a cDNA ...... asminogen activator inhibitor.
@ast
Cloning and sequence of a cDNA ...... asminogen activator inhibitor.
@en
type
label
Cloning and sequence of a cDNA ...... asminogen activator inhibitor.
@ast
Cloning and sequence of a cDNA ...... asminogen activator inhibitor.
@en
prefLabel
Cloning and sequence of a cDNA ...... asminogen activator inhibitor.
@ast
Cloning and sequence of a cDNA ...... asminogen activator inhibitor.
@en
P2093
P2860
P356
P1476
Cloning and sequence of a cDNA ...... asminogen activator inhibitor.
@en
P2093
P2860
P304
P356
10.1073/PNAS.83.18.6776
P407
P577
1986-09-01T00:00:00Z